AF
LGND icon

Amalgamated Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Amalgamated Financial’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$829K Buy
+11,814
New +$857K 0.01% 1272

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Amalgamated Financial's LGND Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Ligand Pharmaceuticals (LGND) in Q1 2022: 11,814 shares worth $829K. The stake represents 0.01% of the portfolio and ranks #1272 among its holdings.

208 funds tracked by Wall St. Rank hold LGND as of Q1 2022.

  • Amalgamated Financial held 11,814 shares of Ligand Pharmaceuticals worth $829K as of Q1 2022.
  • Ligand Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
  • Ligand Pharmaceuticals made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1272 holding.
  • 208 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.